Delve Bio announces data presented at IDWeek showing mNGS RNA and DNA pathogen detection may lower cost of diagnosing meningitis and encephalitis ...
First dual-acting anti-inflammatory and anti-fibrotic candidate in development for FSCD, a condition with no approved therapies Topline safety, PK, and PD data anticipated in Q1 2026 Advances ongoing ...
The Series C round was led by Alphabet Inc.’s GV fund. Sequoia, Kleiner Perkins, Blackstone, Thrive Capital, Coatue, Bond and ...
The federal government has been—and must remain—a critical partner in foundational technological innovation and research ...
In a city, coworking hubs bring people and ideas together. Inside cancer cells, similar hubs form—but instead of fueling ...
Anthropic is doubling down on medical science with Claude for Life Sciences, a specialized AI designed to integrate deeply ...
Zacks Investment Research on MSN
PacBio Aims to Expand Multiomic Capabilities Via Latest Innovations
Pacific Biosciences of California, Inc. PACB, popularly known as PacBio, announced innovations to its Revio and Vega platforms last week. The innovations are expected to lower sequencing costs, add ...
David Crisafulli may not have won over all of southeast Queensland just yet but most of the state seems to be behind the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback